Aug 04 2017
Auris is featured in this TechCrunch article not only for its impressive Series D funding but also for the opportunity it brings with its focus on the lung cancer market. Lung cancer claims more victims than prostate, breast, and colon cancer combined. It remains a very dangerous form of cancer because a diagnosis often comes late, when the cancer has already spread.
Excerpts from the article:
“It’s a huge opportunity (alas). Despite a wealth of information about the dangers of smoking, the World Health Organization estimates that one billion people in the world smoke currently, which leads to 6 million deaths per year.”
“Indeed, it says its technology will allow doctors to access early-stage lung cancer without incisions, allowing for more accurate diagnosis, as well as more targeted treatment.”Read More About Auris